| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
AAV vectors applied to the treatment of CNS disorders: Clinical status and challenges
|
Kang, Lin
|
|
|
355 |
C |
p. 458-473
|
article
|
| 2 |
Albumin-fused long-acting FGF21 analogue for the treatment of non-alcoholic fatty liver disease
|
Chikamatsu, Mayuko
|
|
|
355 |
C |
p. 42-53
|
article
|
| 3 |
A nanodrug combining CD47 and sonodynamic therapy efficiently inhibits osteosarcoma deterioration
|
Gong, Ming
|
|
|
355 |
C |
p. 68-84
|
article
|
| 4 |
Biomimetic synthesis and optimization of extracellular vesicles for bone regeneration
|
Song, Xinyu
|
|
|
355 |
C |
p. 18-41
|
article
|
| 5 |
Brain-neuron targeted nanoparticles for peptide synergy therapy at dual-target of Alzheimer's disease
|
Guo, Qian
|
|
|
355 |
C |
p. 604-621
|
article
|
| 6 |
Carboxylated paclitaxel prodrug nanofibers for enhanced chemotherapy
|
Lu, Shaojin
|
|
|
355 |
C |
p. 528-537
|
article
|
| 7 |
Co-delivery of microRNA-150 and quercetin by lipid nanoparticles (LNPs) for the targeted treatment of age-related macular degeneration (AMD)
|
Li, Wei
|
|
|
355 |
C |
p. 358-370
|
article
|
| 8 |
Comparison of HER2-targeted affibody conjugates loaded with auristatin- and maytansine-derived drugs
|
Yin, Wen
|
|
|
355 |
C |
p. 515-527
|
article
|
| 9 |
Conductive polymers and composites-based systems: An incipient stride in drug delivery and therapeutics realm
|
Kiran Raj, G.
|
|
|
355 |
C |
p. 709-729
|
article
|
| 10 |
Content list including Graphcal Abstracts
|
|
|
|
355 |
C |
p. II-XV
|
article
|
| 11 |
Cooling-induced, localized release of cytotoxic peptides from engineered polymer nanoparticles in living mice for cancer therapy
|
Koide, Hiroyuki
|
|
|
355 |
C |
p. 745-759
|
article
|
| 12 |
Crystallinity-tuned ultrasoft polymeric DNA networks for controlled release of anticancer drugs
|
Nam, Keonwook
|
|
|
355 |
C |
p. 7-17
|
article
|
| 13 |
Cytosolic perfluorocarbon delivery to platelets via albumin for antithrombotic therapy
|
Luo, Lifeng
|
|
|
355 |
C |
p. 109-121
|
article
|
| 14 |
Dry Powder Inhaler with the technical and practical obstacles, and forthcoming platform strategies
|
Gaikwad, Sachin S.
|
|
|
355 |
C |
p. 292-311
|
article
|
| 15 |
Dual-responsive bioconjugates bearing a bifunctional adaptor for robust cytosolic peptide delivery
|
Gao, Xin
|
|
|
355 |
C |
p. 675-684
|
article
|
| 16 |
ECM-targeting bacteria enhance chemotherapeutic drug efficacy by lowering IFP in tumor mouse models
|
Kim, Ji-Sun
|
|
|
355 |
C |
p. 199-210
|
article
|
| 17 |
Editorial Board
|
|
|
|
355 |
C |
p. ii
|
article
|
| 18 |
Efficient intracellular and in vivo delivery of toxin proteins by a ROS-responsive polymer for cancer therapy
|
Lv, Jia
|
|
|
355 |
C |
p. 160-170
|
article
|
| 19 |
Electron transfer-based antioxidant nanozymes: Emerging therapeutics for inflammatory diseases
|
Zhao, Jingnan
|
|
|
355 |
C |
p. 273-291
|
article
|
| 20 |
Emerging plant proteins as nanocarriers of bioactive compounds
|
Hadidi, Milad
|
|
|
355 |
C |
p. 327-342
|
article
|
| 21 |
Engineered liposomes to deliver nucleic acid mimics in Escherichia coli
|
Moreira, Luís
|
|
|
355 |
C |
p. 489-500
|
article
|
| 22 |
Engineering nanoparticles boost TNBC therapy by CD24 blockade and mitochondrial dynamics regulation
|
Zhao, Ming
|
|
|
355 |
C |
p. 211-227
|
article
|
| 23 |
Gastrointestinally absorbable lactoferrin-heparin conjugate with anti-angiogenic activity for treatment of brain tumor
|
Hwang, Hae Hyun
|
|
|
355 |
C |
p. 730-744
|
article
|
| 24 |
Glymphatic-assisted perivascular brain delivery of intrathecal small gold nanoparticles
|
Lilius, Tuomas O.
|
|
|
355 |
C |
p. 135-148
|
article
|
| 25 |
Improving ocular bioavailability of hydrophilic drugs through dynamic covalent complexation
|
Wang, Jing-jie
|
|
|
355 |
C |
p. 395-405
|
article
|
| 26 |
Injectable hydrogels for sustained delivery of extracellular vesicles in cartilage regeneration
|
van de Looij, Sanne M.
|
|
|
355 |
C |
p. 685-708
|
article
|
| 27 |
Inside Back Cover
|
|
|
|
355 |
C |
p. IBC
|
article
|
| 28 |
Inside Front Cover
|
|
|
|
355 |
C |
p. IFC
|
article
|
| 29 |
Intracranial nanomedicine-gel with deep brain-penetration for glioblastoma therapy
|
Das, Devika
|
|
|
355 |
C |
p. 474-488
|
article
|
| 30 |
Lipid nanoparticle-based ribonucleoprotein delivery for in vivo genome editing
|
Onuma, Haruno
|
|
|
355 |
C |
p. 406-416
|
article
|
| 31 |
Liver fibrosis therapy based on biomimetic nanoparticles which deplete activated hepatic stellate cells
|
Xia, Shenglong
|
|
|
355 |
C |
p. 54-67
|
article
|
| 32 |
Modulation of blood-brain tumor barrier for delivery of magnetic hyperthermia to brain cancer
|
Wu, Haoan
|
|
|
355 |
C |
p. 248-258
|
article
|
| 33 |
Nanofibers with genotyped Bacillus strains exhibiting antibacterial and immunomodulatory activity
|
Grilc, Nina Katarina
|
|
|
355 |
C |
p. 371-384
|
article
|
| 34 |
Nanoparticles of VAV1 siRNA combined with LL37 peptide for the treatment of pancreatic cancer
|
Agbaria, Majd
|
|
|
355 |
C |
p. 312-326
|
article
|
| 35 |
Nasal administration of a temozolomide-loaded thermoresponsive nanoemulsion reduces tumor growth in a preclinical glioblastoma model
|
Michels, Luana Roberta
|
|
|
355 |
C |
p. 343-357
|
article
|
| 36 |
Novel sialoglycan linkage for constructing adjuvant-protein conjugate as potent vaccine for COVID-19
|
Wen, Yu
|
|
|
355 |
C |
p. 238-247
|
article
|
| 37 |
Obesity and inflammation influence pharmacokinetic profiles of PEG-based nanoparticles
|
Raith, Mitch
|
|
|
355 |
C |
p. 434-445
|
article
|
| 38 |
Outside Back Cover
|
|
|
|
355 |
C |
p. OBC
|
article
|
| 39 |
Outside Front Cover
|
|
|
|
355 |
C |
p. OFC
|
article
|
| 40 |
Photothermal-triggered dendrimer nanovaccines boost systemic antitumor immunity
|
Shen, Siyan
|
|
|
355 |
C |
p. 171-183
|
article
|
| 41 |
Piperine loaded metal organic frameworks reverse doxorubicin induced chemobrain in adult zebrafish
|
Arora, Sanchit
|
|
|
355 |
C |
p. 259-272
|
article
|
| 42 |
Producing vesicle-free cell culture additive for human cells extracellular vesicles manufacturing
|
Lorenzini, Bileyle
|
|
|
355 |
C |
p. 501-514
|
article
|
| 43 |
Quantitative live-cell imaging of lipidated peptide transport through an epithelial cell layer
|
Hundahl, Adam Coln
|
|
|
355 |
C |
p. 122-134
|
article
|
| 44 |
Rational design of poly-L-glutamic acid-palbociclib conjugates for pediatric glioma treatment
|
Melnyk, Tetiana
|
|
|
355 |
C |
p. 385-394
|
article
|
| 45 |
Recent advances in respiratory immunization: A focus on COVID-19 vaccines
|
He, Xiyue
|
|
|
355 |
C |
p. 655-674
|
article
|
| 46 |
Regulation of protein corona on liposomes using albumin-binding peptide for targeted tumor therapy
|
Li, Hanmei
|
|
|
355 |
C |
p. 593-603
|
article
|
| 47 |
Remote-controllable dosage management through a wearable iontophoretic patch utilizing a cell phone
|
Mori, Kenji
|
|
|
355 |
C |
p. 1-6
|
article
|
| 48 |
Retraction notice to “In vitro and in vivo evaluation of degradation, toxicity, biodistribution, and clearance of silica nanoparticles as a function of size, porosity, density, and composition” [Journal of Controlled Release 311–312 (2019) Pages 1-15]
|
Moghaddam, Seyyed Pouya Hadipour
|
|
|
355 |
C |
p. 622-623
|
article
|
| 49 |
Sex-based differences of antioxidant enzyme nanoparticle effects following traumatic brain injury
|
Tarudji, Aria W.
|
|
|
355 |
C |
p. 149-159
|
article
|
| 50 |
Skin drug delivery using lipid vesicles: A starting guideline for their development
|
Guillot, Antonio José
|
|
|
355 |
C |
p. 624-654
|
article
|
| 51 |
Small molecules as cancer targeting ligands: Shifting the paradigm
|
Kaur, Navjeet
|
|
|
355 |
C |
p. 417-433
|
article
|
| 52 |
Spatiotemporally controllable diphtherin transgene system and neoantigen immunotherapy
|
He, Muye
|
|
|
355 |
C |
p. 538-551
|
article
|
| 53 |
Targeted nanomedicine: Lessons learned and future directions
|
Veiga, Nuphar
|
|
|
355 |
C |
p. 446-457
|
article
|
| 54 |
The application of nanoparticles in immunotherapy for hepatocellular carcinoma
|
Hu, Xinyao
|
|
|
355 |
C |
p. 85-108
|
article
|
| 55 |
TOP-EVs: Technology of Protein delivery through Extracellular Vesicles is a versatile platform for intracellular protein delivery
|
Ilahibaks, Nazma F.
|
|
|
355 |
C |
p. 579-592
|
article
|
| 56 |
Ultrasound-mediated nano drug delivery for treating cancer: Fundamental physics to future directions
|
Moradi Kashkooli, Farshad
|
|
|
355 |
C |
p. 552-578
|
article
|
| 57 |
Vaccine-like nanomedicine for cancer immunotherapy
|
Yi, Yunfei
|
|
|
355 |
C |
p. 760-778
|
article
|
| 58 |
Valency and affinity control of aptamer-conjugated nanoparticles for selective cancer cell targeting
|
Woythe, Laura
|
|
|
355 |
C |
p. 228-237
|
article
|
| 59 |
Yam-derived exosome-like nanovesicles stimulate osteoblast formation and prevent osteoporosis in mice
|
Hwang, Jin-Hyeon
|
|
|
355 |
C |
p. 184-198
|
article
|
Journal description